Skip to main content

Table 1 Descriptive statistics of antimicrobial resistance in ambulatory-onset urine Enterobacterales isolates (2011–2020)

From: A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011–2020

Organism

Antimicrobial resistance

ESBL phenotype

Beta-lactam

Trimethoprim/sulfamethoxazole

Fluoroquinolones

Nitrofurantoin

Tested

NS

% NS

Tested

NS

% NS

Tested

NS

% NS

Tested

NS

% NS

Tested

NS

% NS

All

2,095,447

145,448

6.9

2,228,515

1,280,780

57.5

2,228,515

513,945

23.1

2,228,515

459,339

20.6

2,228,515

450,818

20.2

 E. coli

1,623,448

116,843

7.2

1,623,448

817,083

50.3

1,623,448

422,699

26.0

1,623,448

376,459

23.2

1,623,448

64,194

4.0

 K. pneumoniae

301,628

17,359

5.8

301,628

274,284

90.9

301,628

33,231

11.0

301,628

18,003

6.0

301,628

174,453

57.8

 P. mirabilis

139,204

8991

6.5

139,204

38,423

27.6

139,204

36,105

25.9

139,204

43,767

31.4

139,204

124,276

89.3

 E. cloacae

   

39,007

35,090

90.0

39,007

5442

14.0

39,007

3110

8.0

39,007

25,143

64.5

 K. oxytoca

31,167

2255

7.2

31,167

29,636

95.1

31,167

2939

9.4

31,167

1715

5.5

31,167

5010

16.1

 K. aerogenes

   

30,234

26,770

88.5

30,234

836

2.8

30,234

889

2.9

30,234

23,851

78.9

 C. freundii

   

28,300

25,808

91.2

28,300

4475

15.8

28,300

2668

9.4

28,300

2012

7.1

 M. morganii

   

16,162

15,585

96.4

16,162

5609

34.7

16,162

5799

35.9

16,162

14,296

88.5

 P. stuartii

   

7916

7675

97.0

7916

2272

28.7

7916

5957

75.3

7916

6984

88.2

S. marcsescens

   

11,449

10,426

91.1

11,449

337

2.9

11,449

972

8.5

11,449

10,599

92.6

  1. ESBL extended-spectrum beta-lactamase-producing phenotype, NS not susceptible